Clinical Trial Update: A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy of a docetaxel and carboplatin combination in metastatic malignant melanoma patients who failed first-line daca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Carboplatin (Paraplatin) (carboplatin)
• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: Yonsei University | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED